NVAX, Novavax, Inc       [wikipedia]

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for NVAX

History

Run pick agents

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, Bear Picks, and more.


Short Seller Reports & Red Flags:

News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask NVAX by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:

(ALT) Altimmune, Inc

Latest YouTube Video:

Unlock YouTube Video by Subscribing to iPick.ai Premium!



Billionaire Connection

Not available

Business Profile

Address: 21 Firstfield Road, Gaithersburg, MD, United States, 20878

Employees: 749

Business Summary

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Leadership and Board

Mr. John Charles Jacobs M.B.A.

President, CEO & Director

Mr. James Patrick Kelly C.F.A.

Executive VP, CFO & Treasurer

Mr. Mark J. Casey Esq., J.D.

Executive VP, Chief Legal Officer & Corporate Secretary

Ms. Elaine O'Hara

Executive VP & Chief Strategy Officer

Mr. Richard P. Crowley

Executive VP & COO

Ms. Naina Zaman

Director of Investor Relations

Mr. Troy Morgan Esq., J.D.

Senior VP, Deputy General Counsel & Chief Compliance Officer

Ms. Erika S. Trahan

Associate Director of Investor & Public Relations

Mr. Ian J. Watkins

Executive VP & Chief Human Resources Officer

Ms. Silvia Taylor M.B.A.

Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden